Glomerular diseases
glomerular-diseases · society: KDIGO
Summary
KDIGO 2021 updates the 2012 glomerulonephritis guideline, covering IgA nephropathy/vasculitis, membranous nephropathy, nephrotic syndrome in children, MCD and FSGS in adults, infection-related GN, MPGN/C3 glomerulopathy, ANCA vasculitis, lupus nephritis, and anti-GBM disease. New features include practice points (consensus guidance where evidence is insufficient), risk-stratified treatment for MN, expanded role of rituximab, and recognition that anti-PLA2R serology can diagnose MN without biopsy. Treatment paradigms shift toward minimizing glucocorticoid exposure and individualized risk-based immunosuppression.
Current guideline: KDIGO 2021 Glomerular Diseases Guideline · 
download Anki sub-deck
Versions
- 2021 · KDIGO — KDIGO 2021 Glomerular Diseases Guideline